Non-Invasive Imaging of the Tumor Microenvironment

Tumor Microenvironment

Volumn , Issue , 2010, Pages 229-270

  Jordan, Bénédicte F ^a   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Imaging tumor hypoxia chronic and acute; Imaging tumor oxygen consumption; Imaging tumor vasculature, perfusion and angiogenesis; in vivo molecular imaging, an emerging discipline in medical research; Methods of measuring absolute pO2 electron paramagnetic resonance (EPR) oximetry and 19F relaxometry; Microvascular parameters, permeability and perfusion and abnormal tumor microvascular network; Near infrared spectroscopy (NIRS), gaining importance for non invasive or minimally invasive diagnostic applications in cancer; Nitroxides, as in vivo EPR spectroscopy imaging probes for studying redox mechanisms in disease models; Non invasive imaging of tumor microenvironment; Non invasive imaging impact in oncology guiding preclinical development of targeted biomarkers and therapeutic agents

Indexed keywords

EID: 84863663498     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470669891.ch11     Document Type: Chapter

References (165)

1. Aboagye, E.O., Bhujwalla, Z.M., Shungu, D.C., and Glickson, J.D. (1998) Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. Cancer Research, 58, 1063-1067.
2. Abramovitch, R., Dafni, H., Smouha, E. et al. (1999) In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Research, 59, 5012-5016.
3. Amorino, G.P., Lee, H., Holburn, G.E. et al. (2001) Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13. Radiation Research, 156, 294-300.
4. Ansiaux, R., Baudelet, C., Jordan, B.F. et al. (2006) Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Research, 66, 9698-9704.
5. Ansiaux, R.,Dewever, J., Gregoire,V. et al. (2009) Decrease in tumor cell oxygen consumption after treatment by vandetanib (ZD6474) and its effects on response to radiotherapy. Radiation Research, 172, 584-591.
6. Bammer, R. (2003) Basic principles of diffusion-weighted imaging. European Journal of Radiology, 45, 169-184.
7. Baudelet, C. and Gallez, B. (2002) How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? Magnetic Resonance in Medicine, 48, 980-986.
8. Baudelet, C., Ansiaux, R., Jordan, B.F. et al. (2004) Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Physics in Medicine and Biology, 49, 3389-3411.
9. Baudelet, C., Cron, G.O., and Gallez, B. (2006) Determination of the maturity and functionality of tumor vasculature by MRI: correlation between BOLD-MRI and DCE-MRI using P792 in experimental fibrosarcoma tumors. Magnetic Resonance in Medicine, 56, 1041-1049.
10. Bentzen, L., Vestergaard-Poulsen, P., Nielsen, T. et al. (2005) Intravascular contrast agentenhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascularmodifiers in an experimental tumor. International Journal of Radiation Oncology, Biology, Physics, 61, 1208-1215.
11. Berliner, J.L. and Fujii, H. (1985) Magnetic resonance imaging of biological specimens by electron paramagnetic resonance of nitroxide spin labels. Science, 227, 517-519.
12. Blankenberg, F.G. (2003) Molecular imaging: the latest generation of contrast agents and tissue characterization techniques. Journal of Cellular Biochemistry, 90, 443-453.
13. Bobko, A.A., Dhimitruka, I., Zweier, J.L., and Khramtsov, V.V. (2007) Trityl radicals as persistent dual function pH and oxygen probes for in vivo electron paramagnetic resonance spectroscopy and imaging: concept and experiment. Journal of the American Chemical Society, 129, 7240-7241.
14. Brasch, R.C. (1983) Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. Radiology, 147, 781-788.
15. Brasch, R.C., Li, K.C., Husband, J.E. et al. (2000) In vivo monitoring of tumor angiogenesis with MR imaging. Academic Radiology, 7, 812-823.
16. Bhujwalla, Z.M. and Glickson, J.D. (1996) Detection of tumor response to radiation therapy by in vivo protonMRspectroscopy. International Journal of Radiation Oncology, Biology, Physics, 36, 635-639.
17. Checkley, D., Tessier, J.J., Kendrew, J. et al. (2003) Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. British Journal of Cancer, 89, 1889-1895.
18. Cho, Z.H., Jones, J.P., and Singh, M. (1993) Foundations of Medical Imaging, John Wiley & Sons, Inc., NewYork.
19. Choyke, P.L., Dwyer, A.J., and Knopp, M.V. (2003) Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. Journal of Magnetic Resonance Imaging, 17, 509-520.
20. Christman, D., Crawford, E.J., Friedkin, M., and Wolf, A.P. (1972) Detection of DNA synthesis in intact organisms with positron-emitting [methyl- 11C]thymidine. Proceedings of the National Academy of Sciences of the United States of America, 69, 4.
21. Crokart,N., Jordan, B.F., Baudelet, C. et al. (2007) Glucocorticoidsmodulate tumor radiation response through a decrease in tumor oxygen consumption. Clinical Cancer Research, 13, 630-635.
22. Crokart, N., Radermacher, K., Jordan, B.F. et al. (2005) Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Research, 65, 7911-7916.
23. Dadiani, M., Margalit, R., Sela, N., and Degani, H. (2004) High resolution magnetic resonance imaging of disparities in the transcapillary transfer rates in orthotopically inoculated invasive breast tumors. Cancer Research, 64, 3155-3161.
24. Daldrup, H., Shames, D.M., Wendland, M. et al. (1998) Correlation of dynamic contrastenhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR American Journal of Roentgenology, 171, 941-949.
25. Dennie, J.,Mandeville, J.B., Boxerman, J.L. et al. (1998) NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magnetic Resonance in Medicine, 40, 793-799.
26. De Saint-Hubert, M., Prinsen, K., Mortelmans, L. et al. (2009) Molecular imaging of cell death. Methods, 48, 178-187.
27. DeVries, A.F., Kremser, C., Hein, P.A. et al. (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. International Journal of Radiation Oncology, Biology, Physics, 56, 958-965.
28. Diepart, C., Jordan, B.F., and Gallez, B. (2009) A new EPR oximetry protocol to estimate the tissue oxygen consumption in vivo. Radiation Research, 172, 220-225.
29. Diepart, C., Verrax, J., Calderon, P.B. et al. (2010) Comparison of methods for measuring oxygen consumption in tumor cells in vitro. Analytical Biochemistry, 396, 250-256.
30. Direcks, W.G., Berndsen, S.C., Proost, N. et al. (2008) [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study. British Journal of Cancer, 99, 481-487.
31. Elas, M., Bell, R., Hleihel, D. et al. (2008) Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomas. International Journal of Radiation Oncology, Biology, Physics, 71, 542-549.
32. Enochs, W.S., Harsh, G., Hochberg, F. et al. (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. Journal of Magnetic Resonance Imaging, 9, 228-232.
33. Ferretti, S., Allegrini, P.R., Becquet, M.M., and McSheehy, P.M. (2009) Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics. Neoplasia, 11, 874-881.
34. Ferretti, S., Allegrini, P.R., O'Reilly, T. et al. (2005) Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Clinical Cancer Research, 11, 7773-7784.
35. Frackowiak, R.S., Herold, S., Petty, R.K., and Morgan-Hughes, J.A. (1988) The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. Brain, 111, 1009-1024.
36. Frackowiak, R.S., Lenzi, G.L., Jones, T., and Heather, J.D. (1980) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. Journal of Computed Assisted Tomography, 4, 727-736.
37. Gallagher, F.A., Kettunen, M.I., Day, S.E. et al. (2008) Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature, 453, 940-943.
38. Gallez, B., Bacic, G., Goda, F. et al. (1996) Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies. Magnetic Resonance in Medicine, 35, 97-106.
39. Gallez, B., Baudelet, C., and Jordan, B.F. (2004) Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR in Biomedicine, 17, 240-262.
40. Gallez, B. and Swartz, H.M. (2004) In vivo EPR: when, how and why? NMR in Biomedicine, 17, 223-225.
41. Galons, J.P., Altbach, M.I., Paine-Murrieta, C. et al. (1999) Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia, 1, 113-117.
42. Garcia-Martin, M.L., Martinez, G.V., Raghunand, N. et al. (2006) High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magnetic Resonance in Medicine, 55, 309-315.
43. George, M.L., Dzik-Jurasz, A.S., Padhani, A.R. et al. (2001) Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. British Journal of Surgery, 88, 1628-1636.
44. Geraldesa, C.F.G.C. and Laurent, S. (2009) Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media and Molecular Imaging, 4, 1-23.
45. Gilead, A., Meir, G., and Neeman, M. (2004) The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids. International Journal of Cancer, 108, 524-531.
46. Gillies, R.J., and Morse, D.L. (2005) In vivo magnetic resonance spectroscopy in cancer. Annual Review of Biomedical Engineering, 7, 287-326.
47. Gillies, R.J., Raghunand, N., Garcia-Martin, M.L., and Gatenby, R.A. (2004) pH imaging. A review of pH measurement methods and applications in cancers. EEE Engineering in Medicine and Biology Magazine, 23, 57-64.
48. Gross, D.J., Reibstein, I., Weiss, L. et al. (1999) The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice. Clinical Cancer Research, 5, 3669-3675.
49. Gu, Y., Bourke, V.A., Kim, J.G. et al. (2003) Dynamic response of breast tumor oxygenation to hyperoxic respiratory challenge monitored with three oxygen-sensitive parameters. Applied Optics, 42, 2960-2967.
50. Gulliksrud, K., Brurberg, K.G., and Rofstad, E.K. (2009) Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. Radiotherapy and Oncology, 91, 107-113.
51. Gulsen, G., Yu, H.,Wang, J. et al. (2002) CongruentMRI and near-infrared spectroscopy for functional and structural imaging of tumors. Technology in Cancer Research Treatment, 1, 497-505.
52. Haider, M.A., Sitartchouk, I., Roberts, T.P.L. et al. (2007) Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. Journal of Magnetic Resonance Imaging, 25, 153-159.
53. Hassid, Y., Furman-Haran, E., Margalit, R. et al. (2006) Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Research, 66, 4159-4166.
54. He, X. and Yablonskiy, D.A. (2007) Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magnetic Resonance in Medicine, 57, 115-126.
55. He, X., Zhu, M., and Yablonskiy, D.A. (2008) Validation of oxygen extraction fraction measurement by qBOLD technique. Magnetic Resonance in Medicine, 60, 882-888.
56. Heidelberger, C., Chaudhuri, N.K., Danneberg, P. et al. (1957) Fluorinated pyrimidines, a new class of tumor-inhibitory compounds. Nature, 179, 663.
57. Heldin, C.H., Rubin, K., Pietras, K., and Ostman, A. (2004) High interstitial fluid pressure: an obstacle in cancer therapy. Nature Reviews in Cancer, 4, 806-813.
58. Hou, H., Khan, N., Grinberg, O.Y. et al. (2007) The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice. Radiation Research, 168, 218-225.
59. Howe, F.A., McPhail, L.D., Griffiths, J.R. et al. (2008) Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model. International Journal of Radiation Oncology, Biology, Physics, 71, 1470-1476.
60. Howe, F.A., Robinson, S.P., McIntyre, D.J. et al. (2001) Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR in Biomedicine, 14, 497-506.
61. Hunjan, S., Zhao, D., Constantinescu, A. et al. (2001) Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. International Journal of Radiation Oncology, Biology, Physics, 49, 1097-1108.
62. Hyodo, F., Soule, B.P., Matsumoto, K. et al. (2008) Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging. Journal of Pharmaceutics and Pharmacology, 60, 1049-1060.
63. Ito, M., Lammertsma, A.A., Wise, R.J. et al. (1982) Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumours using 15O and positron emission tomography: analytical techniques and preliminary results. Neuroradiology, 23, 63-74.
64. Jain, R.K. (1987) Transport of molecules in the tumor interstitium: a review. Cancer Research, 47, 3039-3051.
65. Jennings, D., Hatton, B.N., Guo, J. et al. (2002) Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia, 4, 255-262.
66. Jennings, D., Raghunand, N., and Gillies, R.J. (2008) Imaging hemodynamics. Cancer Metastasis Review, 27, 589-613.
67. Jordan, B.F., Christian, N., Crokart, N. et al. (2007) Thyroid status is a key modulator of tumor oxygenation: implication for radiation therapy. Radiation Research, 168, 428-432.
68. Jordan, B.F., Crokart, N., Baudelet, C. et al. (2006) Complex relationship between changes in oxygenation status and changes in R*2: the case of insulin and NS-398, two inhibitors of oxygen consumption. Magnetic Resonance in Medicine, 56, 637-643.
69. Jordan, B.F., Cron, G.O., and Gallez, B. (2009) Rapid monitoring of oxygenation by 19F magnetic resonance imaging: simultaneous comparison with fluorescence quenching. Magnetic Resonance in Medicine, 61, 634-638.
70. Jordan, B.F. and Gillies, R.J. (2008) Post-treatment changes in tumor microenvironment: Dynamic ontrast-enhanced and diffusion-weighted magnetic resonance imaging, in Cancer Imaging, Instrumentations and Applications, vol. 2. (ed. M.A. Hayat), Academic Press, London, pp. 235-246.
71. Jordan, B.F., Grégoire, V., Demeure, R.J. et al. (2002) Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Research, 62, 3555-3561.
72. Jordan, B.F., Misson, P., Demeure, R. et al. (2000) Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. International Journal of Radiation Oncology, Biology, Physics, 48, 565-570.
73. Jordan, B.F., Runquist, M., Raghunand, N. et al. (2005) Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia, 7, 475-485.
74. Kauppinen, R.A. (2002) Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR in Biomedicine, 15, 6-17.
75. Khramtsov, V.V. (2005) Biological imaging and spectroscopy of pH. Current Organic Chemistry, 9, 909-923.
76. Khramtsov, V.V., Marsh, D., Weiner, L., and Reznikov, V.A. (1992) The application of pHsensitive spin labels to studies of surface potential and polarity of phospholipid membranes and proteins. Biochimica et Biophysica Acta, 1104, 317-324.
77. Khramtsov, V.V., Panteleev, M.V., and Weiner, L.M. (1989) ESR study of proton transport across phospholipid vesicle membranes. Journal of Biochemical and Biophysical Methods, 18, 237-246.
78. Kiessling, F.,Huber, P.E.,Grobholz, R. et al. (2004) Dynamicmagnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy. Investigative Radiology, 39, 34-44.
79. Kim, J.G., Zhao, D., Song, Y. et al. (2003) Interplay of tumor vascular oxygenation and tumor pO2 observed using near-infrared spectroscopy, an oxygen needle electrode, and 19F MR pO2 mapping. Journal of Biomedical Optics, 8, 53-62.
80. Knopp, M.V., Giesel, F.L., Marcos, H. et al. (2001) Dynamic contrast-enhanced magnetic resonance imaging in oncology. Topics in Magnetic Resonance Imaging, 12, 301-308.
81. Koh, W.J., Bergman, K.S., Rasey, J.S. et al. (1995) Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F18]fluoromisonidazole positron emission tomography. International Journal of Radiation Oncology, Biology, Physics, 33, 391-398.
82. Kondepati, V.R., Heise, H.M., and Backhaus, J. (2008) Recent applications of near-infrared spectroscopy in cancer diagnosis and therapy. Analytical and Bioanalytical Chemistry, 390, 125-139.
83. Kondepati, V.R., Heise, H.M., and Backhaus, J. (2008) Recent applications of near-infrared spectroscopy in cancer diagnosis and therapy. Analytical and Bioanalytical Chemistry, 390, 125-139.
84. Kragh, M., Quistorff, B., Lund, E.L., and Kristjansen, P.E. (2001) Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy. Neoplasia, 3, 324-330.
85. Krishnan, A.S., Neves, A.A., de Backer, M.M. et al. (2008) Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent. Radiology, 246, 854-862.
86. Kroll, C., Hermann, W., Stösser, R. et al. (2001) Influence of drug treatment on the microacidity in rat and human skin--an in vitro electron spin resonance imaging study. Pharmaceutical Research, 18, 525-530.
87. Kuppusamy, P., Chzhan, M., Vij, K. et al. (1994) Three-dimensional spectral-spatial EPR imaging of free radicals in the heart: a technique for imaging tissue metabolism and oxygenation. Proceedings of the National Academy of Sciences of the United States of America, 91, 3388-3392.
88. Kuppusamy, P., Chzhan, M., and Zweier, J.L. (2003) Principles of imaging in vivo EPR (ESR), in Theory and Applications: Biological Magnetic Resonance, vol. 18 (ed. L.J. Berliner), Kluwer Academic/Plenum, New York, pp. 99-152.
89. Kuppusamy, P., Li, H., Ilangovan, A.J. et al. (2002) Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Research, 62,307-312.
90. Kurhanewicz, J., Vigneron, D.B., and Nelson, S.J. (2000) Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia, 2, 166-189.
91. Lahorte, C.M., Vanderheyden, J.L., Steinmetz, N. et al. (2004) Apoptosis-detecting radioligands: current state of the art and future perspectives. European Journal of Nuclear Medicine in Molecular Imaging, 31, 887-919.
92. Laumonier, C., Segers, J., Laurent, S. et al. (2006) A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. Journal of Biomolecular Screening, 11, 537-545.
93. Li, X., Vigneron, D.B., Cha, S. et al. (2005) Relationship ofMR-derived lactate, mobile lipids and relative blood volume for in vivo gliomas. American Journal of Neuroradiology, 26, 760-769.
94. Loncaster, J.A., Carrington, B.M., Sykes, J.R. et al. (2002) Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. International Journal of Radiation Oncology, Biology, Physics, 54, 759-767.
95. Lutz, N.W., Tome,M.E., and Cozzone, P.J. (2003) Early changes in glucose and phospholipid metabolism following apoptosis induction by IFN-gamma/TNF-alpha inHT-29 cells. FEBS Letters, 544, 123-128.
96. Lyng, H., Tufto, I., Skretting, A., and Rofstad, E.K. (1997) Proton relaxation times and interstitial fluid pressure in human melanoma xenografts. British Journal of Cancer, 75, 180-183.
97. Mäder, K., Bittner, B., Li, Y. et al. (1998) Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks. Pharmaceutical Research, 15, 787-793.
98. Mäder, K., Gallez, B., Liu, K.J., and Swartz, H.M. (1996) Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials, 17, 457-461.
99. Mandl, S.J., Mari, C., Edinger, M. et al. (2004) Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Molecular Imaging, 3, 1-8.
100. Margolis, D.J., Hoffman, J.M., Herfkens, R.J. et al. (2007) Molecular imaging techniques in body imaging. Radiology, 245, 333-356.
101. Marzola, P., Degrassi, A., Calderan, L. et al. (2004) In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model. Clinical Cancer Research, 10, 739-750.
102. Mason, R.P. (1999) Transmembrane pH gradients in vivo: measurements using fluorinated vitamin B6 derivatives. Current Medicinal Chemistry, 6, 481-499.
103. Mason, R.P., Hunjan, S., Constantinescu, A. et al. (2003) Tumor oximetry: comparison of 19F MR EPI and electrodes. Advances in ExpermintalMedicine and Biology, 530, 19-27.
104. Mason, R.P., Rodbumrung, W., and Antich, P.P. (1996) Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation. NMR in Biomedicine, 9, 125-134.
105. Mayr, N.A., Yuh, W.T., Arnholt, J.C. et al. (2000) Pixel analysis ofMR perfusion imaging in predicting radiation therapy outcome in cervical cancer. Journal of Magnetic Resonance Imaging, 12, 1027-1033.
106. Mayr, N.A., Yuh, W.T., Magnotta, V.A. et al. (1996) Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. International Journal Radiation Oncology, Biology, Physics, 36, 623-633.
107. Mayr, N.A., Yuh, W.T., Zheng, J. et al. (1998) Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. American Journal of Roentgenology, 170, 177-182.
108. Moffat, B.A., Hall, D.E., Stojanovska, J. et al. (2004) Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA, 17, 249-259.
109. Nagashima, T., Sakakibara, M., Nakamura, R. et al. (2006) Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients. European Journal of Radiology, 60, 270-274.
110. Neeman, M., Dafni, H., Bukhari, O. et al. (2001) In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magnetic Resonance in Medicine, 45, 887-898.
111. Negendank, W. (1992) Studies of human tumors by MRS: a review. NMR in Biomedicine, 5, 303-324.
112. Ng, P., Rajendran, J.G., Schwartz, D.L. et al. (2003) Can [F-18] fluoromisonidazole PET imaging predict treatment response in head and neck cancer? Journal of Nuclear Medicine, 44, 128P.
113. Norris, D.G. (2001) The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR in Biomedicine, 14, 77-93.
114. Ojugo, A.S., McSheehy, P.M., McIntyre, D.J. et al. (1999) Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous (19)F and (31)P probes. NMR in Biomedicine, 12, 495-504.
115. Ogawa, S., Lee, T.M., Kay, A.R., and Tank, D.W. (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proceedings of the National Academy of Sciences of the United States of America, 87, 9868-9872.
116. Padhani, A.R. (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. Journal of Magnetic Resonance Imaging, 16, 407-422.
117. Padhani, A. (2006) PET imaging of tumour hypoxia. Cancer Imaging, 31, S117-S121.
118. Padhani, A.R. and Husband, J.E. (2001) Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clinical Radiology, 56, 607-620.
119. Padhani, A.R., Krohn, K.A., Lewis, J.S. and Alber, M. (2007) Imaging oxygenation of human tumours. European Radiology, 17 (4), 861-872.
120. Pham, T.H., Hornung, R., Berns, M.W. et al. (2001) Monitoring tumor response during photodynamic therapy using near-infrared photon-migration spectroscopy. Photochemistry and Photobiology, 73, 669-677.
121. Pogue, B.W., O'Hara, J.A., Goodwin, I.A. et al. (2002) Tumor pO(2) changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comparative Biochemistry and Physiology Part A: Molecular and Integrative Physiology, 132, 177-184.
122. Potapenko, D.I., Foster, M.A., Lurie, D.J. et al. (2006) Real-time monitoring of drug-induced changes in the stomach acidity of living rats using improved pH-sensitive nitroxides and low-field EPR techniques. Journal of Magnetic Resonance, 182, 1-11.
123. Rajendran, J.G., Mankoff, D.A., O'Sullivan, F. et al. (2004) Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F] fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clinical Cancer Research, 10, 2245-2252.
124. Rajendran, J.G., Wilson, D.C., Conrad, E.U. et al. (2003) [(18)F] FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. European Journal of Nuclear Medicine andMolecular Imaging, 30, 695-704.
125. Robinson, S.P. and Griffiths, J.R. (2004) Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philosophical Transactions of the Royal Society B: Biological Sciences, 359, 987-996.
126. Robinson, S.P., Howe, F.A., Griffiths, J.R. et al. (2007) Susceptibility contrast magnetic resonance imaging determination of fractional tumour blood volume: a non-invasive imaging biomarker of response to the vascular disrupting agent ZD6126. International Journal of Radiation Oncology, Biology, Physics, 69, 872-879.
127. Robinson, S.P., Kalber, T.L., Howe, F.A. et al. (2005) Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging. Neoplasia, 7, 466-474.
128. Rodrigues, L.M., Howe, F.A., Griffiths, J.R., and Robinson, S.P. (2004) Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. Journal of Magnetic Resonance Imaging, 19, 482-488.
129. Ronen, I., Merkle, H., Ugurbil, K., and Navon, G. (1998) Imaging of H217O distribution in the brain of a live rat by using proton-detected 17O MRI. Proceedings of the National Academy of Sciences of the United States of America, 95, 12934-12939.
130. Ross, B.D., Moffat, B.A., Lawrence, T.S. et al. (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Molecular Cancer Therapeutics, 2, 581-587.
131. Schellenberger, E.A., Bogdanov, A. Jr., Högemann, D. et al. (2002) Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Molecular Imaging, 1, 102-107.
132. Secomb, T.W., Hsu, R., and Dewhirst, M.W. (2004) Synergistic effects of hyperoxic gas breathing and reduced oxygen consumption on tumor oxygenation: a theoretical model. International Journal of Radiation Oncology, Biology, Physics, 59, 572-578.
133. Sheppard, G., Gruzelier, J., Manchanda, R. et al. (1983) 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet, 2, 1448-1452.
134. Shields, A.F. (2006) Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology. Molecular Imaging in Biology, 8, 141-150.
135. Shields, A., Grierson, J., Stayanoff, J. et al. (1998) F-18 FLT can be used to image cell proliferation in vivo. Journal of Nuclear Medicine, 39, 228P.
136. Sijens, P.E., Levendag, P.C., Vecht, C.J. et al. (1996) 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR in Biomedicine, 9, 65-71.
137. Sonveaux, P., Dessy, C., Martinive, P. et al. (2004) Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Research, 64, 3209-3214.
138. Stubbs, M., Bhujwalla, Z.M., Tozer, G.M. et al. (1992) An assessment of 31P MRS as a method of measuring pH in rat tumours. NMR in Biomedicine, 5, 351-359.
139. Subramanian, S., Matsumoto, K., Mitchell, J.B., and Krishna, M.C. (2004) Radio frequency continuous-wave and timedomain EPR imaging and Overhauser-enhanced magnetic resonance imaging of small animals: instrumental developments and comparison of relative merits for functional imaging. NMR in Biomedicine, 17, 263-294.
140. Swartz, H.M. (1990) Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radical Research Communications, 9, 399-405.
141. Swartz, H.M., Khan, N., Buckey, J. et al. (2004) Clinical applications of EPR: overview and perspectives. NMR in Biomedicine, 17, 335-351.
142. Tatum, J.L., Kelloff, G.J., Gillies, R.J. et al. (2006) Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. International Journal of Radiation Biology, 82, 699-757.
143. Tatum, J.L., Kelloff, G.J., Gillies, R.J. (2006) Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. International Journal of Radiation Biology, 82 (10), 699-757.
144. Ter-Pogossian, M.M. and Herscovitch, P. (1985) Radioactive oxygen-15 in the study of cerebral blood flow, blood volume, and oxygenmetabolism. Seminars in NuclearMedicine, 15, 377-394.
145. Theilmann, R.J., Borders, R., Trouard, T.P. et al. (2004) Changes in water mobility measured by diffusionMRI predict response of metastatic breast cancer to chemotherapy. Neoplasia, 6 (6), 831-837.
146. Tofts, P.S., Brix, G., Buckley, D.L. et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging, 10, 223-232.
147. Torigian, D.A., Huang, S.S., Houseni, M., and Alavi, A. (2007) Functional imaging of cancer with emphasis on molecular techniques. CA: A Cancer Journal for Clinicians, 57, 206-224.
148. Tropres, I., Grimault, S., Vaeth, A. et al. (2001) Vessel size imaging. Magnetic Resonance in Medicine, 45, 397-408.
149. Valk, P.E., Bailey, D.L., Townsend, D.W., and Maisey, M.N. (2003) Positron Emission Tomography, Springer-Verlag, London.
150. Viglianti, B.L., Lora-Michiels, M., Poulson, J.M. et al. (2009) Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy. Clinical Cancer Research, 15, 4993-5001.
151. Warburg, O., Wind, F., and Negalein, E. (1927) The metabolism of tumours in the body. Journal of Physiology, 8, 519-530.
152. Xia, M., Kodibagkar,V., Liu, H., and Mason, R.P. (2006) Tumour oxygen dynamicsmeasured simultaneously by near-infrared spectroscopy and 19F magnetic resonance imaging in rats. Physics in Medicine and Biology, 51, 45-60.
153. Yablonskiy, D.A. (1998) Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix. Phantom study. Magnetic Resonance in Medicine, 39, 417-428.
154. Yablonskiy, D.A. and Haacke, E.M. (1994) Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regimen. Magnetic Resonance in Medicine, 32, 749-763.
155. Yamada, K.I., Kuppusamy, P., English, S. et al. (2002) Feasibility and assessment of noninvasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiology, 43, 433-440.
156. Yamashita, Y., Baba, T., Baba, Y. et al. (2000) Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology, 216, 803-809.
157. Zhao, D., Jiang, L., and Mason, R.P. (2004) Measuring changes in tumor oxygenation. Methods in Enzymology, 386, 378-418.
158. Zhao, M., Beauregard, D.A., Loizou, L. et al. (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature in Medicine, 7, 1241-1244.
159. Zhao, D., Constantinescu, A., Chang, C.H. et al. (2003) Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiation Research, 159, 621-631.
160. Zhu, X.H., Zhang, Y., Tian, R.X. et al. (2002) Development of (17)O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field. Proceedings of the National Academy Sciences of the United States of America, 99, 13194-13199.
161. Zhu, X.H., Zhang, N., Zhang, Y. et al. (2005) In vivo 17O NMR approaches for brain study at high field. NMR in Biomedicine, 18, 83-103.
162. Koo, V., Hamilton, P.W., and Williamson, K. (2006) Non-invasive in vivo imaging in small animal research. Cellular Oncology, 28, 127-139.
163. van Laarhoven,H.W., Klomp, D.W., Rijpkema,M. et al. (2007) Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil. NMR in Biomedicine, 20, 128-140.
164. Sotgiu, A., M̈ader, K., Placidi, G. et al. (1998) pH-sensitive imaging by low-frequency EPR: a model study for biological applications. Physics inMedicine and Biology, 43, 1921-1930.
165. Zhang, N., Zhu, X.H., Lei, H. et al. (2004) Simplified methods for calculating cerebral metabolic rate of oxygen based on 17O magnetic resonance spectroscopic imaging measurement during a short 17O2 inhalation. Journal of Cerebral Blood Flow andMetabolism, 24, 840-848.